Categories: News

Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life

SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ — Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third iteration of the innovative device delivers significant enhancements, including an extended shelf life, improved ease of use, and streamlined preparation, directly addressing critical feedback from physician users.

- Advertisement -

The highly anticipated Sniper G3 features a 24-month shelf life, doubling the longevity of its predecessor. This improvement offers greater inventory flexibility for hospitals and clinics. Designed with direct input from interventional radiologists, Sniper G3 also features improved trackability and a simplified preparation process, significantly reducing pre-procedure setup time. The new prep method eliminates several steps, cutting preparation time down to less than a minute, a crucial gain in fast-paced clinical environments. This focus on user feedback underscores Embolx’s commitment to developing intuitive, high-performance tools that enhance clinical workflow.

- Advertisement -

Sniper G3 truly exemplifies our dedication to innovation driven by physician needs,” said Michael Allen, President and CEO of Embolx. “We listened intently to our users and engineered a device that not only extends product longevity and improves performance, but also significantly enhances the ease of use, which translates directly to more efficient procedures. We are incredibly proud of Sniper G3 and its potential to set a new standard in embolization therapy.”

- Advertisement -

The Sniper G3 Balloon Occlusion Microcatheter represents a significant leap forward in Embolx’s commitment to physician-centric innovation. It is available in all standard lengths and is ready for worldwide distribution.

- Advertisement -

About Embolx
Embolx has pioneered advanced pressure-mediated delivery of therapeutics directly into cancerous tumors, prostates, and other anatomical structures and is dedicated to transforming healthcare through the development of innovative technologies.

- Advertisement -

For media inquiries, please contact:

- Advertisement -

Haley McGregor
Global Marketing and Sales Operations Manager
hmcgregor@embolx.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2738641/Sniper_g3_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/embolx-launches-sniper-g3-revolutionizing-embolization-with-enhanced-efficiency-ease-of-use-and-extended-shelf-life-302514310.html

- Advertisement -

Recent Posts

A Pint for Kim Blood Drive Breaks Illinois Record for the Seventh Year in a Row with over 650 Donations in One Day

NAPERVILLE, Ill., May 09, 2026 (GLOBE NEWSWIRE) -- A Pint for Kim, the national grassroots…

5 hours ago

Crypto News: AlphaPepe Announces Stage 16 Presale Live Whilst Ethereum Price Prediction Points To $8,000

MONACO City, Monaco, May 09, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe…

13 hours ago

New Crypto: AlphaPepe Presale Stage 15 Sells Out Amid Rising Bitcoin Price Prediction To $250,000

MONACO , May 09, 2026 (GLOBE NEWSWIRE) -- New crypto buyers are turning toward AlphaPepe…

13 hours ago

The AI trading bots launched by BsStrategy open a new gateway to automated quantitative trading for 2026

BsStrategy Logo NEW YORK, May 09, 2026 (GLOBE NEWSWIRE) -- The growing interest in automated…

13 hours ago